跳至主要内容
临床试验/NCT07597122
NCT07597122招募中不适用

MIRSEP - MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK

Insel Gruppe AG, University Hospital Bern1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2026年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
56
试验地点
1
主要终点
Difference in the miRNA-expression pattern in critically ill patients with/without sepsis-induced immunosuppression

研究概览

简要总结

Sepsis-induced immunosuppression (SIS) is a common complication in patients with septic shock. Reduced expression of Human leukocyte antigen isotype DR (HLA-DR) on circulating monocytes is a marker for SIS and correlates with risk of secondary infections and mortality. The miRSep study aims to improve the understanding of early microRNA (miRNA) mediated changes in HLA-DR on monocytes in patients with septic shock.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Septic shock:
  • New onset (<24h) of septic shock diagnosis according to Sepsis-3 definition
  • (suspected) infection
  • Vasopressors required to maintain mean arterial pressure ≥65mm Hg (despite adequate fluid resuscitation)
  • Serum lactate level > 2mmol/L
  • Minimum age of 18 years
  • Expected length of stay >48h
  • Written consent from an independent physician
  • Critically ill:
  • Patients on mechanical ventilation (MV) in the ICU without an admission diagnosis of sepsis/septic shock according to Sepsis-3 definition
  • Minimum age of 18 years
  • Expected length of stay >48h
  • Written consent from an independent physician

排除标准

  • Age < 18 years
  • Patients known not to speak German or French
  • Patients with known.
  • Pre-existing congenital or acquired severe immune deficiency (e.g. severe combined immunodeficiency, HIV infection, AIDS) or
  • current immunosuppressive therapy (immunosuppressive biologicals or active lymphocyte therapy e.g. endoxan, rituximab or corticosteroid use at a dose > 10 mg/day equivalent of prednisone. However, acute corticosteroid treatment of a relative adrenal insufficiency using a maximum hydrocortisone dose of 200 mg/day is accepted.

研究组 & 干预措施

Critically ill patients

Critically ill patients in ICU without sepsis diagnosis

Septic shock

Patients in ICU with diagnosed septic shock

结局指标

主要结局

Difference in the miRNA-expression pattern in critically ill patients with/without sepsis-induced immunosuppression

时间窗: 3 Days following ICU admission

Determine the early expression of specific miRNA candidates in monocytes of patients with sepsis induced immunosuppression compared to critically ill patients without sepsis induced immunosuppression using quantification by RT-qPCR

次要结局

  • Correlation between miRNA expression and sepsis outcome (30-day mortality)(30 days following ICU admission)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK | 临床试验